Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-001727
Filing Date
2024-01-08
Accepted
2024-01-08 08:02:02
Documents
3
Period of Report
2024-01-08

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea191300-6k_alterity.htm 6-K 13778
2 ALTERITY COMPLETES TRANCHE TWO OF PLACEMENT RAISING A$3.5M ea191300ex99-1_alterity.htm EX-99.1 17574
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4231
  Complete submission text file 0001213900-24-001727.txt   38469
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 24518411
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)